Switch to:
Also traded in: Germany, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.08
PAH's Cash-to-Debt is ranked lower than
91% of the 985 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.84 vs. PAH: 0.08 )
Ranked among companies with meaningful Cash-to-Debt only.
PAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.08  Med: 0.18 Max: N/A
Current: 0.08
Equity-to-Asset 0.27
PAH's Equity-to-Asset is ranked lower than
87% of the 944 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.54 vs. PAH: 0.27 )
Ranked among companies with meaningful Equity-to-Asset only.
PAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.25 Max: 0.54
Current: 0.27
0.21
0.54
Interest Coverage 0.67
PAH's Interest Coverage is ranked lower than
97% of the 979 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 38.42 vs. PAH: 0.67 )
Ranked among companies with meaningful Interest Coverage only.
PAH' s Interest Coverage Range Over the Past 10 Years
Min: 0.25  Med: 0.86 Max: N/A
Current: 0.67
Piotroski F-Score: 5
Altman Z-Score: 0.81
WACC vs ROIC
17.59%
1.07%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 7.06
PAH's Operating Margin % is ranked higher than
52% of the 961 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.82 vs. PAH: 7.06 )
Ranked among companies with meaningful Operating Margin % only.
PAH' s Operating Margin % Range Over the Past 10 Years
Min: 1.13  Med: 7.07 Max: 15.74
Current: 7.06
1.13
15.74
Net Margin % -2.05
PAH's Net Margin % is ranked lower than
85% of the 962 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.56 vs. PAH: -2.05 )
Ranked among companies with meaningful Net Margin % only.
PAH' s Net Margin % Range Over the Past 10 Years
Min: -12.14  Med: -2.06 Max: 6.29
Current: -2.05
-12.14
6.29
ROE % -1.64
PAH's ROE % is ranked lower than
84% of the 947 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.00 vs. PAH: -1.64 )
Ranked among companies with meaningful ROE % only.
PAH' s ROE % Range Over the Past 10 Years
Min: -15.04  Med: -7.61 Max: 1.03
Current: -1.64
-15.04
1.03
ROA % -0.70
PAH's ROA % is ranked lower than
82% of the 986 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.09 vs. PAH: -0.70 )
Ranked among companies with meaningful ROA % only.
PAH' s ROA % Range Over the Past 10 Years
Min: -4.19  Med: -0.81 Max: 7.46
Current: -0.7
-4.19
7.46
ROC (Joel Greenblatt) % 20.39
PAH's ROC (Joel Greenblatt) % is ranked higher than
68% of the 979 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.65 vs. PAH: 20.39 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.34  Med: 13.38 Max: 99.98
Current: 20.39
1.34
99.98
GuruFocus has detected 4 Warning Signs with Platform Specialty Products Corp $PAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PAH's 10-Y Financials

Financials (Next Earnings Date: 2017-05-28 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

PAH Guru Trades in Q1 2016

Paul Singer 1,446,500 sh (New)
David Dreman 1,352 sh (New)
First Eagle Investment 57,800 sh (New)
John Griffin 12,785,000 sh (unchged)
Bill Ackman 42,737,394 sh (unchged)
Ron Baron Sold Out
Murray Stahl 3,915,356 sh (-3.72%)
» More
Q2 2016

PAH Guru Trades in Q2 2016

Mario Gabelli 20,000 sh (New)
RS Investment Management 15,010 sh (New)
John Griffin 12,785,000 sh (unchged)
David Dreman 1,352 sh (unchged)
Bill Ackman 42,737,394 sh (unchged)
First Eagle Investment Sold Out
Paul Singer Sold Out
Murray Stahl 3,707,185 sh (-5.32%)
» More
Q3 2016

PAH Guru Trades in Q3 2016

Jim Simons 187,100 sh (New)
Paul Tudor Jones 90,812 sh (New)
Larry Robbins 10,294,598 sh (New)
Mario Gabelli 47,000 sh (+135.00%)
John Griffin 12,785,000 sh (unchged)
Bill Ackman 42,737,394 sh (unchged)
David Dreman 1,352 sh (unchged)
Murray Stahl 3,482,334 sh (-6.07%)
» More
Q4 2016

PAH Guru Trades in Q4 2016

Paul Singer 10,951,281 sh (New)
Paul Tudor Jones 345,342 sh (+280.28%)
Larry Robbins 13,847,112 sh (+34.51%)
Mario Gabelli 60,000 sh (+27.66%)
Jim Simons 215,200 sh (+15.02%)
John Griffin 12,785,000 sh (unchged)
David Dreman 1,352 sh (unchged)
Bill Ackman 40,451,506 sh (-5.35%)
Murray Stahl 932,507 sh (-73.22%)
» More
» Details

Insider Trades

Latest Guru Trades with PAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325998    SIC: 2899
Compare:NYSE:CBT, NYSE:SXT, OTCPK:TINLY, OTCPK:OCINY, NYSE:POL, NYSE:FUL, NYSE:GRA, NYSE:NGVT, NYSE:GCP, OTCPK:OCLDY, NYSE:CHMT, NYSE:NEU, OTCPK:VTXPF, NYSE:OLN, NYSE:SCL, NYSE:KRO, NYSE:KWR, OTCPK:COIHF, OTCPK:ELMTY, NAS:WDFC » details
Traded in other countries:PLQ.Germany, PAH.UK,
Platform Specialty Products Corp is a producer of high technology specialty chemical products and provider of post-sale technical services.

Platform Specialty Products Corp was incorporated under the laws of the British Virgin Islands on April 23, 2013. The Company's businesses include the manufacture of a broad range of specialty chemicals, which it create by blending raw materials, and the incorporation of these chemicals into multi-step technological processes. These specialty chemicals and processes together encompass the products and sells in the electronics, metal and plastic plating, graphic arts, and offshore oil production and drilling industries. The Company has two operating segments: Performance Solutions and Agricultural Solutions. The Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in automotive production, commercial packaging and printing, electronics, and oil and gas production and drilling. Its products include surface and coating materials, functional conversion coatings, electronics assembly materials, water-based hydraulic control fluids and photopolymers. Within this segment, the Company provides specialty chemicals to the following industries, Electronics, Commercial Packing and Printing, Industrial, and Offshore. The Agricultural Solutions segment is based on a solutions-oriented business model that focuses on product innovation to address an ever-increasing need for higher crop yield and quality. It offers to growers diverse crop protection solutions from weeds (herbicides), insects (insecticides) and diseases (fungicides), in foliar and seed treatment applications. It also offers proven biosolutions, including biostimulants, nutrition and biocontrol products. It emphasize on farmer economics and food safety by combining, when possible, biosolutions with crop protection and seed treatment agrochemicals. The Company competes in markets for specialty chemicals for agrochemicals, electronic applications, general metal and plastic finishing, oil and gas exploration and production, and printing. The Company is subject to federal, state and local laws and regulations.

Guru Investment Theses on Platform Specialty Products Corp

Bill Ackman Comments on Platform Specialty Products Corp - Dec 09, 2016

In September, Platform (NYSE:PAH) hosted an investor day where it provided a detailed explanation of the secular growth drivers and unique competitive positioning of each of its Performance and Agricultural Solutions businesses, along with long-term guidance of 4% annual organic revenue growth and high-single digit annual EBITDA growth.

The company also announced that it had reached a revised agreement with Permira to settle its $600 million preferred stock liability related to the Arysta acquisition. Under the revised agreement, Platform has the option to pay Permira $450 million in cash and 5.5 million shares, which equates to $500 million at the current market prices and represents a savings of $100 million relative to the original agreement. To finance the cash portion of the agreement, the company raised $400 million of equity and, as a result, was able to refinance $2 billion of its debt, reducing the rate on this debt by 50 basis points and extending the maturities by three years to 2023.

At the beginning of November, Platform reported strong third quarter earnings. The company delivered 3% organic revenue growth, comprised of 4% growth in Agricultural Solutions and 2% in Performance Solutions. The results are particularly impressive given the cyclical weakness in the company’s end markets. EBITDA grew 14%, due to 5% growth before synergies and corporate costs, 6% impact from net synergies, and 3% from FX.

From Bill Ackman (Trades, Portfolio)'s Pershing Square third-quarter shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Aug 29, 2016

Platform (NYSE:PAH)'s earnings declined in the second quarter as positive results in Performance Solutions, increased cost synergies, and strong growth in the International Ag Solutions were offset by a significant decline in the North American Ag Solutions business and increased corporate costs.

Platform's organic revenue increased 1% as Ag Solutions grew 5% and Performance Solutions revenue declined 2%. Ag Solutions achieved double-digit growth outside of North America (more than 80% of segment revenue), which was offset by a more than 40% decline in North America. The decline in North America resulted from the continued reduction in distributor channel inventories, decreased demand for pesticides due to lower pest pressures, and lower market share. The company stated that it has made changes to its sales force and product development initiatives and expects these efforts to improve business results over time. Performance Solutions' organic revenue declined primarily due to weakness in the electronics market in Asia, which the company noted should return to growth in the second half of the year.

Platform's organic EBITDA was down nearly 6%, as the growth in Performance Solutions and cost synergies were more than offset by the decline in Ag Solutions and higher corporate costs. In Performance Solutions, organic EBITDA increased 4%, as an improved sales mix of higher-margin products and cost synergies more than offset an increase in corporate expenses. In Ag Solutions, organic EBITDA declined 15%, as the higher sales mix of lower-margin products and the declines in the relatively higher-margin North American business more than offset increased cost synergies. Reported EBITDA declined 10% due to the negative headwinds from FX. As a result, EPS declined 36% due to the negative impact of financial leverage.

While Platform delivered mixed performance for the quarter, we are starting to see business progress under Platform's new CEO Rakesh Sachdev. We think highly of Rakesh and believe he possesses the necessary leadership qualities and experience to improve the performance of Platform.

From Bill Ackman (Trades, Portfolio)'s mid-year 2016 letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products Corp - May 11, 2016

Platform (NYSE:PAH) reported modestly improved underlying earnings due to strong cost synergies from its recent acquisitions, which were offset by weakness in several key end markets and an increase in corporate costs. Reported earnings were lower than the prior year due to significant headwinds from FX. Still, earnings beat expectations leading to a substantial increase in PAH’s stock price.

Platform’s organic revenue declined 1% as Ag Solutions was flat and Performance Solutions was down 2%. Ag Solutions achieved solid growth in Europe and Latin America, which was offset by market weakness in North America. Performance Solutions’ organic revenue declined primarily due to weakness in the electronics market in Asia. Although several of the company’s end markets have softened recently, Platform’s underlying results continue to outpace its competitors. Platform’s organic EBITDA was up slightly, as the benefit of cost synergies more than offset the increase in corporate costs. In Ag Solutions, organic EBITDA increased 3%, as higher cost synergies more than offset the increase in corporate expenses. In Performance Solutions, organic EBITDA declined 2%, as cost synergies were more than offset by the increase in corporate expenses. Reported EBITDA declined 6% due to the negative headwinds from FX. As a result, EPS declined nearly 30% due to the negative impact from financial leverage.

Based on its first quarter results, Platform reaffirmed its 2016 EBITDA guidance. The company also announced it would hold an investor day in September, where it will provide an update on strategy and longer-term financial outlook.

From Bill Ackman (Trades, Portfolio)'s first quarter shareholder letter.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Jan 27, 2016

Our most glaring, albeit small, unforced error was buying additional stock in Platform Specialty Products (NYSE:PAH) at $25 per share to assist the company in financing an acquisition. We paid too much as we assumed the new transaction would create substantial value, and because we assigned too much platform value to the company. Our assessment was incorrect as execution difficulties, operating issues, currency effects, and financing issues have destroyed rather than created value.

From Bill Ackman (Trades, Portfolio)'s Pershing Square Annual Investor Letter 2015.

Check out Bill Ackman latest stock trades

Bill Ackman Comments on Platform Specialty Products - Dec 16, 2015

Platform Specialty Products (NYSE:PAH)

During the third quarter, PAH’s share price declined 51%. While there were several developments at the company which contributed to the decline in the share price, many companies that have been highly acquisitive or compete in the agricultural chemicals industry also experienced significant share price declines during the quarter. For example, highly acquisitive companies such as XPO Logistics, Altice, and Colfax each exhibited share price declines of between 35% and 47% during the quarter, and the share price of FMC, PAH’s closest agricultural peer, declined 35% during the same period.

During the last several months, PAH announced the resignation, hiring, and promotion of several key executive roles. In August, Wayne Hewett, former President and head of the agricultural solutions business, left the company. In October, Dan Leever, the CEO of PAH, resigned. Dan stated that his resignation occurred due to disagreements with Chairman Martin Franklin regarding management style and the cultural integration of acquired companies. PAH also recently hired a new CFO, Sanjiv Khattri, and promoted its former head of corporate development, Ben Gliklich, to COO. On an investor call in October, Martin reiterated his commitment to PAH and explained that his involvement with the company will be even greater than it has been in the past. Martin and other members of the board and management have made substantial stock purchases in recent weeks.

PAH has reduced its EBITDA guidance twice in 2015. In August, the company reduced 2015 EBITDA guidance by approximately 5% from its initial guidance in March. In October, PAH further reduced its 2015 EBITDA guidance by an additional 12%. The company has explained that the primary drivers of the guidance reductions are worsening foreign exchange rates and a change in distribution strategy in the agricultural solutions business to realign inventory levels to more closely match underlying demand.

During the quarter, the company provided additional details regarding the financing for its pending acquisition of Alent. In October, PAH reiterated that it had obtained an underwritten commitment for long-term debt financing at what it believes to be competitive market rates for the $1.8 billion cash portion of the purchase price. In addition, the company clarified that it does not need to issue additional equity to finance the closing of the Alent acquisition. On December 1st, Platform completed its acquisition of Alent.

While Platform is clearly a work in progress, we have a high degree of confidence in Martin Franklin and his team. Yesterday, Martin’s largest holding, Jarden Corp., where he has served as Executive Chair, agreed to be acquired by Newell Rubbermaid. Under Martin’s leadership, Jarden’s stock price has increased approximately 50 times. Martin will be stepping down as Executive Chair, but will remain on the board of the merged company. We view this sale as favorable for Platform and Nomad Foods as he will now be able to devote more of his time to these companies.

From Bill Ackman (Trades, Portfolio)'s Pershing Square Holdings third quarter 2015 letter to shareholders.

Check out Bill Ackman latest stock trades

Top Ranked Articles about Platform Specialty Products Corp

Bill Ackman Comments on Platform Specialty Products Corp Guru stock highlight
In September, Platform (NYSE:PAH) hosted an investor day where it provided a detailed explanation of the secular growth drivers and unique competitive positioning of each of its Performance and Agricultural Solutions businesses, along with long-term guidance of 4% annual organic revenue growth and high-single digit annual EBITDA growth. Read more...
Bill Ackman's Pershing Square Returns Slide in October Losses deepen at fund
Bill Ackman (Trades, Portfolio)’s Pershing Square returns slumped lower for the third straight month in October as stock prices of most of the holdings in his concentrated portfolio descended. Read more...
Bill Ackman Comments on Platform Specialty Products Guru stock highlight
Platform (NYSE:PAH)'s earnings declined in the second quarter as positive results in Performance Solutions, increased cost synergies, and strong growth in the International Ag Solutions were offset by a significant decline in the North American Ag Solutions business and increased corporate costs. Read more...
Bill Ackman Comments on Platform Specialty Products Corp Guru stock highlight
Platform (NYSE:PAH) reported modestly improved underlying earnings due to strong cost synergies from its recent acquisitions, which were offset by weakness in several key end markets and an increase in corporate costs. Reported earnings were lower than the prior year due to significant headwinds from FX. Still, earnings beat expectations leading to a substantial increase in PAH’s stock price. Read more...

Ratios

vs
industry
vs
history
Forward PE Ratio 20.41
PAH's Forward PE Ratio is ranked lower than
67% of the 132 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 17.30 vs. PAH: 20.41 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 1.26
PAH's PB Ratio is ranked higher than
66% of the 1030 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.97 vs. PAH: 1.26 )
Ranked among companies with meaningful PB Ratio only.
PAH' s PB Ratio Range Over the Past 10 Years
Min: 0.65  Med: 1.55 Max: 2.71
Current: 1.26
0.65
2.71
PS Ratio 0.91
PAH's PS Ratio is ranked higher than
64% of the 1020 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.27 vs. PAH: 0.91 )
Ranked among companies with meaningful PS Ratio only.
PAH' s PS Ratio Range Over the Past 10 Years
Min: 0.47  Med: 1.54 Max: 15.89
Current: 0.91
0.47
15.89
Price-to-Free-Cash-Flow 32.60
PAH's Price-to-Free-Cash-Flow is ranked lower than
83% of the 450 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 16.55 vs. PAH: 32.60 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PAH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.38  Med: 33.7 Max: 153.03
Current: 32.6
4.38
153.03
Price-to-Operating-Cash-Flow 20.69
PAH's Price-to-Operating-Cash-Flow is ranked lower than
86% of the 526 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.54 vs. PAH: 20.69 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.72  Med: 21.85 Max: 138.27
Current: 20.69
3.72
138.27
EV-to-EBIT 33.93
PAH's EV-to-EBIT is ranked lower than
83% of the 916 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.14 vs. PAH: 33.93 )
Ranked among companies with meaningful EV-to-EBIT only.
PAH' s EV-to-EBIT Range Over the Past 10 Years
Min: 29.7  Med: 98.9 Max: 1128.9
Current: 33.93
29.7
1128.9
EV-to-EBITDA 20.15
PAH's EV-to-EBITDA is ranked lower than
77% of the 941 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.77 vs. PAH: 20.15 )
Ranked among companies with meaningful EV-to-EBITDA only.
PAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 17.3  Med: 55.8 Max: 1128.9
Current: 20.15
17.3
1128.9
Current Ratio 1.91
PAH's Current Ratio is ranked higher than
53% of the 845 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.84 vs. PAH: 1.91 )
Ranked among companies with meaningful Current Ratio only.
PAH' s Current Ratio Range Over the Past 10 Years
Min: 1.91  Med: 2.92 Max: 6.55
Current: 1.91
1.91
6.55
Quick Ratio 1.53
PAH's Quick Ratio is ranked higher than
59% of the 845 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.32 vs. PAH: 1.53 )
Ranked among companies with meaningful Quick Ratio only.
PAH' s Quick Ratio Range Over the Past 10 Years
Min: 1.53  Med: 2.33 Max: 5.69
Current: 1.53
1.53
5.69
Days Inventory 93.10
PAH's Days Inventory is ranked lower than
72% of the 926 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 64.39 vs. PAH: 93.10 )
Ranked among companies with meaningful Days Inventory only.
PAH' s Days Inventory Range Over the Past 10 Years
Min: 36.92  Med: 80.2 Max: 120.72
Current: 93.1
36.92
120.72
Days Sales Outstanding 107.37
PAH's Days Sales Outstanding is ranked lower than
87% of the 766 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 57.94 vs. PAH: 107.37 )
Ranked among companies with meaningful Days Sales Outstanding only.
PAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.37  Med: 124.53 Max: 146.87
Current: 107.37
69.37
146.87
Days Payable 67.37
PAH's Days Payable is ranked higher than
65% of the 727 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 49.64 vs. PAH: 67.37 )
Ranked among companies with meaningful Days Payable only.
PAH' s Days Payable Range Over the Past 10 Years
Min: 51.84  Med: 77.29 Max: 106.01
Current: 67.37
51.84
106.01

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -40.00
PAH's 3-Year Average Share Buyback Ratio is ranked lower than
95% of the 483 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -1.30 vs. PAH: -40.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -40  Med: 0 Max: 0
Current: -40
-40
0

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.57
PAH's Price-to-Median-PS-Value is ranked higher than
94% of the 952 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.38 vs. PAH: 0.57 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.44  Med: 0.64 Max: 2.28
Current: 0.57
0.44
2.28
Earnings Yield (Greenblatt) % 2.99
PAH's Earnings Yield (Greenblatt) % is ranked lower than
69% of the 1043 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.71 vs. PAH: 2.99 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.1  Med: 1 Max: 3.4
Current: 2.99
0.1
3.4

More Statistics

Revenue (TTM) (Mil) $3,586
EPS (TTM) $ -1.41
Beta3.32
Short Percentage of Float20.38%
52-Week Range $6.85 - 13.96
Shares Outstanding (Mil)284.25

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 3,706 3,844 3,989
EPS ($) 0.61 0.95 1.35
EPS without NRI ($) 0.61 0.95 1.35
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for PAH

Headlines

Articles On GuruFocus.com
Bill Ackman Expands Chipotle Position, Cuts Zoetis Feb 15 2017 
Bill Ackman Comments on Platform Specialty Products Corp Dec 09 2016 
Bill Ackman Slumps Further in October Nov 02 2016 
Hedge Funds Push Back on Buffett With Index Beat in August Sep 09 2016 
Bill Ackman Comments on Platform Specialty Products Aug 29 2016 
Bill Ackman’s Portfolio Returns Diminish as Stock Prices Decline Jul 19 2016 
Learn from Bill Ackman’s Mistakes Jul 18 2016 
Bill Ackman Comments on Platform Specialty Products Corp May 11 2016 
Bill Ackman’s Fund Falls by Double Digits Again in January Feb 02 2016 
Pershing Square's New Presentation, Part 2 Jan 29 2016 

More From Other Websites
Platform Specialty Products Corp. breached its 50 day moving average in a Bullish Manner : PAH-US :... Mar 23 2017
BASF, on the sidelines of merger wave, eyes generic pesticides Mar 22 2017
PLATFORM SPECIALTY PRODUCTS CORP Files SEC form 8-K, Change in Directors or Principal Officers Mar 16 2017
Platform Specialty Products Corporation Announces Changes to Leadership Structure Mar 16 2017
PLATFORM SPECIALTY PRODUCTS CORP Financials Mar 16 2017
PLATFORM SPECIALTY PRODUCTS CORP Files SEC form 8-K, Results of Operations and Financial Condition Mar 13 2017
PLATFORM SPECIALTY PRODUCTS CORP Files SEC form 10-K, Annual Report Mar 13 2017
Platform Specialty Products Corporation to Present at the 29th Annual ROTH Conference Mar 07 2017
Cramer’s Exec Cut: 4 signs of global growth in the Trump ... Mar 03 2017
Platform Specialty Products: Cramer's Top Takeaways Mar 03 2017
Platform Specialty Products Corp. :PAH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2,... Mar 02 2017
Arysta LifeScience Announces Increase in R&D Pipeline Value Feb 28 2017
Edited Transcript of PAH earnings conference call or presentation 28-Feb-17 1:30pm GMT Feb 28 2017
Platform Specialty Products Corp Earnings Call scheduled for 8:30 am ET today Feb 28 2017
Platform Specialty beats 4Q profit forecasts Feb 28 2017
Platform Specialty beats 4Q profit forecasts Feb 28 2017
Q4 2016 Platform Specialty Products Corp Earnings Release - Before Market Open Feb 28 2017
PLATFORM SPECIALTY PRODUCTS CORP Files SEC form 8-K, Results of Operations and Financial Condition Feb 28 2017
Platform Specialty Products Corporation Announces 2016 Fourth Quarter and Full Year Financial... Feb 28 2017
Why Platform Specialty Products (PAH) Might Surprise This Earnings Season Feb 27 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)